1. MGMT inhibition regulates radioresponse in GBM, GSC, and melanoma
   Hong Shik Yun et al, 2024, Scientific Reports CrossRef
2. The Impact of IDH1 Mutation and MGMT Promoter Methylation on Recurrence-Free Interval in Glioblastoma Patients Treated With Radiotherapy and Chemotherapeutic Agents
   Maher Kurdi et al, 2021, Pathology and Oncology Research CrossRef
3. Prognostic and Predictive Biomarkers in Gliomas
   Paulina Śledzińska et al, 2021, International Journal of Molecular Sciences CrossRef
4. Implications of Advances in Studies of O6-Methylguanine-DNA- Methyltransferase for Tumor Prognosis and Treatment
   Yuexia Chen et al, 2023, Frontiers in Bioscience-Landmark CrossRef
5. LAT4 drives temozolomide induced radiotherapy resistance in glioblastoma by enhancing mTOR pathway activation
   Wenrui Zang et al, 2024, Cancer Cell International CrossRef
6. The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas
   Arne Christians et al, 2019, Acta Neuropathologica Communications CrossRef
7. MGMT Promoter Methylation as a Prognostic Factor in Primary Glioblastoma: A Single-Institution Observational Study
   Mateusz Szylberg et al, 2022, Biomedicines CrossRef